On Demand Therapeutics (ODTx) is developing implantable devices to enable on-demand release of drugs to the back of the eye, controlled by the ophthalmologist, leveraging existing equipment and skills. In addition to its own intellectual property, ODTx has acquired rights to the patent portfolio and technical expertise developed by InterWest company MicroCHIPS in the areas of implantable drug delivery and monitoring devices.